University of Wisconsin, Madison: Breast Neoplasms trials

The registry lists 43 Breast Neoplasms studies with University of Wisconsin, Madison as lead sponsor. 4 are open to participants now and 14 have results posted.

Early Phase 1 2Phase 1 3Phase 2 20Phase 3 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast CancerNot yet recruitingNCT07706179Phase 2
• Study of 18F-FFNP Breast PET/MRIRecruitingNCT06086704Phase 2
• Biomarkers to Detect Endocrine Therapy ResistanceRecruitingNCT06067503Phase 2
• Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast CancerRecruitingNCT03936478Phase 2
• ICG and SLN MappingCompletedNCT05859971Early Phase 1Results posted
• Intraoperative Evaluation of Axillary LymphaticsCompletedNCT05094102Not applicableResults posted
• Pain Control for Breast Cancer Patients Receiving Injection of Radioactive TracerCompletedNCT04822597Phase 3Results posted
• Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)TerminatedNCT04738292Phase 2Results posted
• ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast CancerTerminatedNCT03733119Phase 2Results posted
• Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCISCompletedNCT03703492Phase 2Results posted
• Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast CancerCompletedNCT03301350Phase 2Results posted
• FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast CancerCompletedNCT03212170Phase 2Results posted
• Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRTerminatedNCT02720185Phase 2Results posted
• Dose Dense TC + Pegfilgrastim Support for Breast CancerCompletedNCT01671319Phase 2Results posted
• Estrogen for Triple Negative Breast CancerTerminatedNCT01083641Phase 2Results posted
• Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast CancerTerminatedNCT00574236Phase 2Results posted
• Multi-catheter High Dose Rate (HDR) Breast BrachytherapyTerminatedNCT00214149Phase 2Results posted
• Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast CancerCompletedNCT00213980Phase 2Results posted
• Outcomes and Cosmesis With Whole Breast Irradiation and BoostActive, not recruitingNCT06295744Not applicable
• Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast CancerCompletedNCT05609435Not applicable
• Remote Electronic Assessment of Survivors With Feedback Communication and Directed ReferralsCompletedNCT05047575Not applicable
• Evaluation of PSMA in HER2- AR+ Metastatic Breast CancerCompletedNCT04573231Phase 2
• Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic PainCompletedNCT04075097Not applicable
• Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor BiopsyTerminatedNCT03393741
• Implementation of a Web-based Decision Aid for Breast Cancer SurgeryCompletedNCT03304002
• A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast CancerTerminatedNCT03186937Phase 2
• Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma ResponsesWithdrawnNCT03185871Phase 2
• Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-MakingCompletedNCT03116035Not applicable
• Pilot Study of Bisphosphonates for Breast CancerTerminatedNCT02781805Phase 1
• Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinCompletedNCT02677389Not applicable
• The Plan and Stand Study: Reducing Sitting Time in Breast Cancer SurvivorsCompletedNCT02510430Not applicable
• Post-Treatment Surveillance in Breast Cancer: Bringing CER to the AllianceCompletedNCT02171078
• A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast CancerCompletedNCT01808040Phase 1
• Educational Intervention for Reducing Work Disability in Breast Cancer SurvivorsCompletedNCT01799031Not applicable
• Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast CancerCompletedNCT01263613Early Phase 1
• Moderating the Negative Impact of Abnormal Screening MammogramsCompletedNCT01153126Not applicable
• Study of Biomarkers in Tissue Samples From Patients With Breast CancerStatus unknownNCT01004796
• Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer RliskCompletedNCT00839696
• Component and Couple Analysis of Cancer CommunicationsCompletedNCT00468741Not applicable
• Evaluation of Breast Cancer Surgical Margins Using Optical SpectroscopyCompletedNCT00214292Not applicable
• XELOX for Metastatic Breast CancerCompletedNCT00204776Phase 2
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
• Perillyl Alcohol in Treating Patients With Metastatic Breast CancerCompletedNCT00003219Phase 2